PTGS2 and neoplasm: Although the mechanisms by which celecoxib inhibits the growth of the tumor in vivo are currently unclear, our data suggests that celecoxib exerts its anti-tumorigenic effects in the KpB ovarian cancer mouse model via a COX-2-dependent pathway through induction of apoptosis, inhibition of tumor angiogenesis and reduction of the cell proliferation index.